Adani Enterprises

Adani Enterprises will join the NSE Nifty 50 index, the
most tracked stocks gauge in the country, replacing Shree Cement Limited,
according to a statement on Thursday from the National Stock Exchange of
India’s index-management firm. Adani Enterprises shares have risen 89% this
year, while all seven listed companies have rallied, led by a 310% growth in
Adani Power Ltd. In Nifty Next 50, Adani Total Gas, Bharat Electronics, Hindustan
Aeronautics, Indian Railway Catering and Tourism Corporation (IRCTC), Mphasis,
Samvardhana Motherson, and Shree Cement will replace Adani Enterprises,
Jubilant Foodworks, Lupin, Mindtree, Punjab National Bank, Steel Authority of
India, and Zydus Life.

Also Read | Asian stocks trade mixed ahead of US payroll data

Hero MotoCorp

The auto major reported a 1.92% increase in total sales at
4,62,608 units in August 2022 against 4,53,879 units in the year-ago period.
Domestic sales stood at 4,50,740 units as compared to 4,31,137 units in August
2021, a growth of 4.55%. However, exports declined to 11,868 units from 22,742
units in the corresponding period of last year. Motorcycle sales were up at
4,30,799 units last month against 4,20,609 units in the preceding year, scooter
sales declined to 31,809 units against 33,270 units in August last year.

Also Read | US Stock Market: DJIA, S&P500, Nasdaq, Russell ended mixed on Thursday

Infosys

The IT services major has completed the acquisition of
Europe-based life sciences consulting and technology firm BASE life science.
BASE further expands Infosys’ footprint in the Nordics region and will bring
domain experts with commercial, medical, digital marketing, clinical,
regulatory, and quality know-how.

Also Read | Trade Setup: Top 13 things to know before market opens on September 2, 2022

RattanIndia Power

The company board of directors has appointed Rajiv Rattan
as an Executive Chairman of the company for a period of five years with effect
from October 1, 2022. Rajiv, a part of the promoter group, is currently a
non-executive Chairman.

Also Read | Oil prices rise on prospect of OPEC+ output cut

Aurobindo Pharma

Aurobindo Pharma’s wholly-owned subsidiary, CuraTeQ
Biologics, plans to invest around Rs 300 crore in the capacity expansion of
biologics manufacturing facilities. The board of directors approved the
expansion of its operations by establishing another mammalian cell culture
manufacturing facility of higher capacity to cater to future requirements. The
capital expenditure for ramping up capacities is estimated to be around Rs 300
crore. The facility is likely to be fully operational by the financial year
2025-26. The company plans to explore possibilities to offer contract
manufacturing services to global vaccine developers to effectively utilize its
existing manufacturing capacity.

Also Read | Starbucks names former PepsiCo executive Laxman Narasimhan as new CEO

Ramco Systems

Enterprise aviation software provider Ramco Systems
Corporation, USA announced that its US subsidiary Ramco Systems Defense and
Security Incorporated (RSDSI) has secured a contract from General Atomics
Aeronautical Systems, Inc. (GA-ASI). Ramco will implement its Aviation M&E
MRO Suite V5.9 for GA-ASI’s SkyGuardian Global Support Solutions (SGSS)
program.

Also Read | Google will not host Donald Trump’s Truth Social on Play Store, here’s why

SIS

The company’s Australia-based subsidiary SIS Australia
Group Pty Limited has signed a share purchase agreement for buying an 85% stake
in Safety Direct Solutions Pty Ltd which provides critical risk management,
medical and training services. The company will complete the acquisition by
September 30 and the transaction cost is around AUD 5 million.